Cerecor Inc.
METHODS FOR TREATING SYMPTOMATIC ORTHOSTATIC HYPOTENSION
Last updated:
Abstract:
The present disclosure provides a method for treating symptomatic orthostatic hypotension using a potent selective antagonist of N-methyl-D-aspartate receptor subunit 2B (NMDA-GluN2B or NR2B).
Status:
Application
Type:
Utility
Filling date:
18 Mar 2020
Issue date:
2 Jun 2022